Creative Biolabs

Creative Biolabs logo

Creative Biolabs is a leading company of recombinant antibody (rAb) discovery and manufacturing, providing high quality service to customers in academia and industry fields all over the world. Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price.

Company Website

Product Listing

Abatacept 1 mg  | >90%

Creative Biolabs

Abatacept is a soluble fusion protein, which links the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) to the modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1). Structurally, abatacept is a glycosylated fusion protein with a MALDI-MS molecular weight of 92,300 Da and it is a homodimer of two […]

More Information Supplier Page

Abciximab 1 mg  | >90%

Creative Biolabs

Abciximab is a Fab fragment of the chimeric human-murine monoclonal antibody 7E3. Abciximab binds to the glycoprotein (GP) IIb/IIIa receptor of human platelets and inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules. It also binds to vitronectin (αvβ3) receptor found on platelets and vessel wall endothelial and […]

More Information Supplier Page

Adalimumab 1 mg  | >90%

Creative Biolabs

Adalimumab is a human monoclonal antibody against TNF-alpha. It is produced by recombinant DNA technology using a mammalian cell expression system. It consists of 1330 amino acids and has a molecular weight of approximately 148 kilodaltons.

More Information Supplier Page

Afuco™ Anti-HIV gp41 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HIV gp41 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-HIV-1 gp41 antibodies are used for a therapeutic treatment against HIV infection by reducing viral load levels within an infected individual, thus prolonging the asymptomatic phase of HIV infection. https://www.creativebiolabs.net/Anti-HIV-gp41-ADCC-Enhanced-Antibody-20647.htm

More Information Supplier Page

Afuco™ Anti-Human CSPG4 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-CSPG4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies bind to the membrane-proximal domain (MP) of human Melanoma-Associated Chondroitin Sulphate Proteoglycan (MCSP) and are capable of mediating cytolysis of a cell expressing MCSP in the presence of human effector cells or complement. They can be used to treat […]

More Information Supplier Page

Afuco™ Anti-Human CTSS ADCC Theraputic Antibody (Fsn0503h), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-CTSS ADCC Enhanced Antibody (Fsn0503h) is an ADCC enhanced antibody produced by our Afuco™ platform. Fsn0503h is a fully human anti-Cathepsin S antibody with anti-tumor and anti-angiogenic properties. Cathepsin S is a cysteine protease highly expressed in many cancers including colorectal, breast, prostate and glioblastomas. It is involved in tumor progression through extracellular matrix remodeling. […]

More Information Supplier Page

Afuco™ Anti-Human CXCL12 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-CXCL12 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The human monoclonal antibodies that specifically bind to SDF-1 with high affinity can be used for detecting SDF-1, as well as treating various B cell malignancies, including breast cancer, multiple myeloma and non-Hodgkin’s lymphoma, and autoimmune disorders. https://www.creativebiolabs.net/Anti-CXCL12-ADCC-Enhanced-Antibody-20495.htm

More Information Supplier Page

Afuco™ Anti-Human DCHS1 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-DCHS1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a human antibody capable of binding to human CDH19 on the surface of a target cell, it can be used for the treatment or amelioration of a melanoma disease or metastatic melanoma disease. https://www.creativebiolabs.net/Anti-DCHS1-ADCC-Enhanced-Antibody-20502.htm

More Information Supplier Page

Afuco™ Anti-Human DKK1 ADCC Theraputic Antibody (BHQ880), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-DKK1 ADCC Enhanced Antibody (BHQ880) is an ADCC enhanced antibody produced by our Afuco™ platform. BHQ880 is a human neutralizing IgG1 anti-DKK1 monoclonal antibody, that is being investigated for its impact on multiple myeloma-related bone disease and as an agent with potential anti-myeloma activity. BHQ880 in combination with zoledronic acid and anti-myeloma therapy was well […]

More Information Supplier Page

Afuco™ Anti-Human DLK1 ADCC Theraputic Antibody (LIV-1205), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-DLK1 ADCC Enhanced Antibody (LIV-1205) is an ADCC enhanced antibody produced by our Afuco™ platform. LIV-1205 is a humanized monoclonal antibody targeting cell surface antigen “DLK-1 (Delta-like 1 homolog)” of liver cancer and other solid cancers. DLK-1 is expected to control the proliferation and differentiation of stem cells, progenitor cells, and other immature cells. LIV-1205 […]

More Information Supplier Page

Afuco™ Anti-Human ECSCR ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-ECSCR ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. They are antibodies which bind ECSCR and inhibit chemotaxis. The antibodies may bind an epitope QTVPPNSTTM on the extracellular domain of ECSCR. The antibodies, which may be provided as a pharmaceutical composition, may be used to inhibit tumour cell invasion and […]

More Information Supplier Page

Afuco™ Anti-Human EMB ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-EMB ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is an anti-Embigin antibody showing cytotoxicity or cytotoxicity inducing activity, and an agent the prophylaxis or therapy of autoimmune diseases or allergic diseases. https://www.creativebiolabs.net/Anti-EMB-ADCC-Enhanced-Antibody-20524.htm

More Information Supplier Page

Afuco™ Anti-Human EPHA10 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-EPHA10 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies specifically bind to the Ephrin type-A receptor 10 with high affinity, used for treating various cancers, including bladder cancer, breast cancer, colorectal cancer, head and neck cancer, kidney cancer, lung cancer, uterine cancer and pancreatic cancer. https://www.creativebiolabs.net/Anti-EPHA10-ADCC-Enhanced-Antibody-20530.htm

More Information Supplier Page

Afuco™ Anti-Human EPHA4 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-EPHA4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies specific for EphA4 inhibit a cancer cell phenotype, preferentially bind epitopes on EphA4 that are selectively exposed or increased on cancer cells but not non-cancer cells and/or bind EphA4. The antibodies are useful for hyperproliferative cell disease, particularly cancer […]

More Information Supplier Page

Afuco™ Anti-Human Ferritin ADCC Theraputic Antibody (AMB8LK), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-Ferritin ADCC Enhanced Antibody (AMB8LK) is an ADCC enhanced antibody produced by our Afuco™ platform. AMB8LK is a chimeric monoclonal antibody specifically recognizing H-ferritin, using for pancreatic cancer, hepatocarcinomas and neuroblastomas. Preclinical studies showed that the immunoconjugate with 90Y has 98% stability over 7 days. The DTPA-AMB8LK has a high reactivity with ferritin. The results […]

More Information Supplier Page

Afuco™ Anti-Human FGF19 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-FGF19 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-FGF19 antibodies provide important therapeutic and diagnostic agents for use in targeting pathological conditions associated with expression and/or activity of the FGF19-FGFR4 pathways. https://www.creativebiolabs.net/Anti-FGF19-ADCC-Enhanced-Antibody-20571.htm

More Information Supplier Page

Afuco™ Anti-Human FGF2 ADCC Theraputic Antibody (HuGAL-F2), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-FGF2 ADCC Enhanced Antibody (HuGAL-F2) is an ADCC enhanced antibody produced by our Afuco™ platform. HuGAL-F2 is a humanized monoclonal antibody being to Fibroblast Growth Factor 2, effectively inhibits the growth of hepatocellular carcinoma xenografts. https://www.creativebiolabs.net/Anti-FGF2-ADCC-Enhanced-Antibody-HuGAL-F2-20572.htm

More Information Supplier Page

Afuco™ Anti-Human FGF21 ADCC Theraputic Antibody (ARX618), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-FGF21 ADCC Enhanced Antibody (ARX618) is an ADCC enhanced antibody produced by our Afuco™ platform. ARX618 is an antibody binds to Fibroblast Growth Factor 21 (FGF-21) protein, used for the treatment of diabetes and heart failure. https://www.creativebiolabs.net/Anti-FGF21-ADCC-Enhanced-Antibody-ARX618-20573.htm

More Information Supplier Page

Afuco™ Anti-Human FGFR4 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-FGFR4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The FGFR4 antibodies are suitable for diagnosing, preventing and/or treatment of diseases associated with FGFR4 expression. FGFR4 has been found to be expressed and/or influencing the prognostic outcome in several types of cancer such as melanoma, breast, prostate, thyroid and pancreatic […]

More Information Supplier Page

Afuco™ Anti-Human GPNMB ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-GPNMB ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies to GPNMB play an important role in numerous cell types, as well as in tumors. https://www.creativebiolabs.net/Anti-GPNMB-ADCC-Enhanced-Antibody-20622.htm

More Information Supplier Page

Afuco™ Anti-Human HAMP ADCC Theraputic Antibody (LY2787106), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HAMP ADCC Enhanced Antibody (LY2787106) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a fully-humanized antibody against hepcidin currently in phase I human trials for cancer-related anemia. https://www.creativebiolabs.net/Anti-HAMP-ADCC-Enhanced-Antibody-LY2787106-20630.htm

More Information Supplier Page

Afuco™ Anti-Human HAVCR1 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HAVCR1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that bind to human TIM-1 on the BED face of the protein are used to treat or prevent immunological disorders such as inflammatory and autoimmune conditions. https://www.creativebiolabs.net/Anti-HAVCR1-ADCC-Enhanced-Antibody-20631.htm

More Information Supplier Page

Afuco™ Anti-Human HBEGF ADCC Theraputic Antibody (KHK2866), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HBEGF ADCC Enhanced Antibody (KHK2866) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a monoclonal antibody targeting anti-heparin-binding EGF-like growth factor (HB-EGF), which was being developed for the treatment of advanced solid tumors and ovarian cancer. https://www.creativebiolabs.net/Anti-HBEGF-ADCC-Enhanced-Antibody-KHK2866-20632.htm

More Information Supplier Page

Afuco™ Anti-Human HCV-E2 ADCC Theraputic Antibody (HuMax-HepC), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HCV-E2 ADCC Enhanced Antibody (Humax-HepC) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a fully human therapeutic monoclonal antibody targeting the E2 envelope protein of the Hepatitis C Virus (HCV). It is a promising candidate for the development of immunoprophylaxis against HCV infection. https://www.creativebiolabs.net/Anti-HCV-E2-ADCC-Enhanced-Antibody-HuMax-HepC-20637.htm

More Information Supplier Page

Afuco™ Anti-Human HGFAC ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HGFAC ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies binding to HGFA are used for the therapeutic and/or prophylactic treatment of a disease, such as cancer, tumor, cell proliferative disorder, an immune (such as autoimmune) disorder and angiogenesis-related disorder. https://www.creativebiolabs.net/Anti-HGFAC-ADCC-Enhanced-Antibody-20642.htm

More Information Supplier Page

Afuco™ Anti-Human HIGD1A ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HIGD1A ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a monoclonal antibody against a human HIG-1 polypeptide, the antibody binding to at least one epitope included in the amino acid sequence at positions 1-19 of a human HIG-1 polypeptide; Hypoxia-induced gene 1 (HIG-1) was reported as one of […]

More Information Supplier Page

Afuco™ Anti-Human HIV V3 ADCC Theraputic Antibody (KD-247), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HIV V3 ADCC Enhanced Antibody (KD-247) is an ADCC enhanced antibody produced by our Afuco™ platform. KD-247 is an anti-V3 humanized antibody that effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection. https://www.creativebiolabs.net/Anti-HIV-V3-ADCC-Enhanced-Antibody-KD-247-20648.htm

More Information Supplier Page

Afuco™ Anti-Human HLA-DR βchain ADCC Theraputic Antibody (1D09C3), ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HLA-DR βchain ADCC Enhanced Antibody (1D09C3) is an ADCC enhanced antibody produced by our Afuco™ platform. 1D09C3 is a human monoclonal IgG4-type antibody against human leukocyte antigen-DR (HLA-DR) which has demonstrated pro-apoptotic activity against lymphoid tumors in vitro and in vivo. 1D09C3 could be administered safely in patients with advanced B cell malignancies. https://www.creativebiolabs.net/Anti-HLA-DR-βchain-ADCC-Enhanced-Antibody-1D09C3-20652.htm

More Information Supplier Page

Afuco™ Anti-Human HS6ST2 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HS6ST2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that bind to HS6ST2 proteins are used for diagnosing cancer, HS6ST2 proteins conjugated to cytotoxic agents and pharmaceutical compositions comprising the HS6ST2 proteins as active ingredients. https://www.creativebiolabs.net/Anti-HS6ST2-ADCC-Enhanced-Antibody-20658.htm

More Information Supplier Page

Afuco™ Anti-Human HSP90 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HSP90 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-HSP90 antibody is capable of recognizing cell surface HSP90 with high sensitivity, and hence is capable of detecting cell surface HSP90 of living cell in FACS analysis. Because of its capability to specifically recognize cell surface HSP90 with high sensitivity, […]

More Information Supplier Page

Afuco™ Anti-Human HSPA5 ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-HSPA5 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-GRP78 antibodies that bind specifically to the cell surface of cancer cells, leading to the accomplishment of treatment for cancer. https://www.creativebiolabs.net/Anti-HSPA5-ADCC-Enhanced-Antibody-20661.htm

More Information Supplier Page

Afuco™ Anti-SUDV Ebola GP ADCC Theraputic Antibody, ADCC Enhanced 1mg  | Purity Not Available

Creative Biolabs

Anti-Ebola GP ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies to Ebola GP can be used for the detection, prevention, and/or therapeutical treatment of Ebola virus infections in vitro and in vivo. https://www.creativebiolabs.net/Anti-Ebola-GP-ADCC-Enhanced-Antibody-20516.htm

More Information Supplier Page

Agalsidase beta 1 mg  | >90%

Creative Biolabs

Recombinant human alpha-galactosidase A. The mature protein is composed of 2 subunits of 398 residues. Protein is glycosylated and produced by CHO cells

More Information Supplier Page

Aldesleukin 1 mg  | >90%

Creative Biolabs

Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Genetic engineering techniques were used to modify the human IL-2 gene, and the resulting expression clone encodes a modified human interleukin-2. This recombinant form differs from native interleukin-2 in the following […]

More Information Supplier Page

Alefacept 1 mg  | >90%

Creative Biolabs

Immunosuppressive dimeric fusion protein that consists of the extracellular CD2-binding portion of the human leukocyte function antigen-3 (LFA-3) linked to the Fc (hinge, CH2 and CH3 domains) portion of human IgG1. Produced by CHO cells, mW is 91.4 kD.

More Information Supplier Page

Alemtuzumab 1 mg  | >90%

Creative Biolabs

Humanized monoclonal antibody specific to lymphocyte antigens. It is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) that is directed against the 21-28 kD cell surface glycoprotein,CD52. The Campath-1H antibody is an IgG1 kappa with human variable framework and constant regions, and complementarity-determining regions from a murine (rat) monoclonal antibody (Campath-1G). Campath is produced in mammalian […]

More Information Supplier Page

Alglucerase 1 mg  | >90%

Creative Biolabs

Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 3.2.1.45. 497 residue protein with N-linked carbohydrates, MW=59.3 kD. Alglucerase is prepared by modification of the oligosaccharide chains of human Beta-glucocerebrosidase. The modification alters the sugar residues at the non-reducing ends of the oligosaccharide chains of the glycoprotein so that they are predominantly terminated with mannose residues

More Information Supplier Page

Alglucosidase alfa 1 mg  | >90%

Creative Biolabs

Aglucosidase alfa consists of the human enzyme acid alpha-glucosidase (GAA) which is essential for the degradation of glygogen to glucose in lysosomes. It is encoded by the most predominant of nine observed haplotypes of this gene. Aglucosidase alfa is produced by recombinant DNA technology in a Chinese hamster ovary cell line. Alglucosidase alfa degrades glycogen […]

More Information Supplier Page

Alpha-1-proteinase inhibitor 1 mg  | >90%

Creative Biolabs

Human alpha-1 proteinase inhibitor or alpha-1-antitrypsin, prepared from human plasma via Cohn alcohol fractionation followed by PEG and zinc chloride fractionation.

More Information Supplier Page

alpha-Amanitin – fungal fermentation origin 1 mg  | >95%

Creative Biolabs

ADCs Toxins, alpha-Amanitin, a cyclic peptide, consisting of eight amino acids.The source of this specific alpha-Amanitin is fungal fermentation. By this production method the supply problems are solved. alpha-Amanitin is an inhibitor of RNA polymerase II (0.02 micrograms/ml). RNA polymerase I was also inhibited by the relatively high concentration of alpha-amanitin (IC50 = 100 micrograms/ml […]

More Information Supplier Page